Cited by 175Gastrointestinal motility and disordersGastroesophageal reflux and treatmentsDiabetes Management and Research

Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1

Open access
Kashyap, Purna, Farrugia, Gianrico·2010·Gut

Abstract

Diabetic gastroparesis is a disorder that occurs in both type 1 and type 2 diabetes. It is associated with considerable morbidity among these patients and with the resultant economic burden on the health system. It is primarily a disease seen in middle-aged women, although the increased predisposition in women still remains unexplained. Patients often present with nausea, vomiting, bloating, early satiety and abdominal pain. The pathogenesis of this complex disorder is still not well understood but involves abnormalities in multiple interacting cell types including the extrinsic nervous system, enteric nervous system, interstitial cells of Cajal (ICCs), smooth muscles and immune cells. The primary diagnostic test remains gastric scintigraphy, although other modalities such as breath test, capsule, ultrasound, MRI and single photon emission CT imaging show promise as alternative diagnostic modalities. The mainstay of treatment for diabetic gastroparesis has been antiemetics, prokinetics, nutritional support and pain control. In recent years, gastric stimulation has been used in refractory cases with nausea and vomiting. As we better understand the pathophysiology, newer treatment modalities are emerging with the aim of correcting the underlying defect. In this review, what has been learned about diabetic gastroparesis in the past 5 years is highlighted. The epidemiology, pathogenesis, diagnosis and treatment of diabetic gastroparesis are reviewed, focusing on the areas that are still controversial and those that require more studies. There is also a focus on advances in our understanding of the cellular changes that underlie development of diabetic gastroparesis, highlighting new opportunities for targeted treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2009.199703

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Gastroparesis profoundly affects postprandial glycemic excursions, insulin requirements, and the overall management of diabetes.

    “As a consequence, gastroparesis profoundly affects postprandial glycemic excursions, insulin requirements, and the overall management of diabetes [15, 19, 23, 88, 89].”

    From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [89]

    The Pathogenesis section says gastric-emptying rate is a major determinant of the initial postprandial glycemic response and that delayed emptying can cause hypoglycemia in insulin-treated people. The Treatment section says erratic emptying affects glycemic control, supporting its relevance to diabetes management. Neither passage states that gastroparesis changes insulin requirements. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The interplay between autonomic neuropathy, impaired enteric neurotransmission, and loss or dysfunction of interstitial cells of Cajal produces a motility disorder that disrupts the temporal coordination between meal ingestion, gastric processing, intestinal absorption, and insulin pharmacodynamics.

    “The interplay between autonomic neuropathy, impaired enteric neurotransmission, and loss or dysfunction of interstitial cells of Cajal produces a motility disorder that disrupts the temporal coordination between meal ingestion, gastric processing, intestinal absorption, and insulin pharmacodynamics.”

    From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [89]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [65]McCallum RW Lin Z Damjanov I Interstitial cells of cajal in the stomach of patients with gastroparesis Neurogastroenterol Motil 2006 18 758 19614868

Cited by

Sorted by citations

Authors
Kashyap, P., & Farrugia, G.
Affiliations
Mayo Clinic (US)
Corresponding author
Farrugia, Gianrico
Venue
Gut
Publisher
BMJ
Published
2010-09-25
Volume
59
Issue
12
Pages
1716-1726
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2119082327
Cited by
175
References
120
Citations by year
2026: 5 · 2025: 3 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 7 · 2020: 14 · 2019: 6 · 2018: 14 · 2017: 10 · 2016: 12 · 2015: 6 · 2014: 17 · 2013: 23 · 2012: 20
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK074008, DK57061, DK-68055, P01DK068055, R01DK057061, U01DK074035)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetic gastroparesis, type 1 diabetes, type 2 diabetes, pathogenesis, interstitial cells of Cajal, enteric nervous system, gastric emptying scintigraphy, gastric emptying, antiemetics, prokinetic agents, gastric electrical stimulation, nausea and vomiting, sex differences, targeted therapy
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Gastroenterology, Humans, Sex Factors, Gastroparesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review